{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:22:18Z","timestamp":1777396938561,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,5,7]]},"DOI":"10.3233\/jad-181016","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T13:53:53Z","timestamp":1554213233000},"page":"49-58","source":"Crossref","is-referenced-by-count":9,"title":["Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"69","author":[{"given":"Moira","family":"Marizzoni","sequence":"first","affiliation":[{"name":"Laboratory of Neuroimaging and Alzheimer\u2019s Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}]},{"name":"The PharmaCog Consortium","sequence":"additional","affiliation":[]},{"given":"Clarissa","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Unit of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}]},{"given":"Ambra","family":"Macis","sequence":"additional","affiliation":[{"name":"Unit of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}]},{"given":"Jorge","family":"Jovicich","sequence":"additional","affiliation":[{"name":"Center for Mind\/Brain Sciences, University of Trento, Italy"}]},{"given":"Diego","family":"Albani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"}]},{"given":"Claudio","family":"Babiloni","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology \u201cV. Erspamer\u201d, Sapienza University of Rome, Rome, Italy"},{"name":"Hospital San Raffaele Cassino, Cassino (FR), Italy"}]},{"given":"Libera","family":"Cavaliere","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging and Alzheimer\u2019s Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}]},{"given":"Mira","family":"Didic","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9, Inserm, INS UMR_S 1106, Marseille, France"},{"name":"APHM, Timone, Service de Neurologie et Neuropsychologie, APHM H\u00f4pital Timone Adultes, Marseille, France"}]},{"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy"}]},{"given":"Samantha","family":"Galluzzi","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging and Alzheimer\u2019s Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}]},{"given":"Karl-Titus","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, University of Leipzig, Leipzig, Germany"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease Unit and Other Cognitive Disorders Unit, Hospital Cl\u00ednic de Barcelona, and Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain"}]},{"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[{"name":"Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy"},{"name":"Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[{"name":"Clinica Neurologica, Universit\u00e0 di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy"}]},{"given":"Pierre","family":"Payoux","sequence":"additional","affiliation":[{"name":"INSERM; Imagerie c\u00e9r\u00e9brale et handicaps neurologiques UMR 825, Toulouse, France"}]},{"given":"Francesca","family":"Pizzini","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Pathology, Neuroradiology, Verona University Hospital, Italy"}]},{"given":"Paolo Maria","family":"Rossini","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Area of Neuroscience, Neurosciences & Orthopedics, Catholic University, Policlinic A. Gemelli Foundation Rome, Italy"}]},{"given":"Marco","family":"Salvatore","sequence":"additional","affiliation":[{"name":"IRCCS SDN, Napoli"}]},{"given":"Peter","family":"Sch\u00f6nknecht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany"}]},{"given":"Andrea","family":"Soricelli","sequence":"additional","affiliation":[{"name":"IRCCS SDN, Napoli"}]},{"given":"Claudio","family":"Del Percio","sequence":"additional","affiliation":[{"name":"IRCCS SDN, Napoli"}]},{"given":"Tilman","family":"Hensch","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany"}]},{"given":"Ulrich","family":"Hegerl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[{"name":"3rd Neurologic Clinic, Medical School, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, The Netherlands"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, LVR-Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August-University, Goettingen, Germany"},{"name":"iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal"}]},{"given":"Jill C.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, UK"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm, CHU Lille, U1171-Degenerative and vascular cognitive disorders, Lille, France"}]},{"given":"Olivier","family":"Blin","sequence":"additional","affiliation":[{"name":"Aix Marseille University, UMR-CNRS 7289, Service de Pharmacologie Clinique, AP-HM, Marseille, France"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging and Alzheimer\u2019s Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"},{"name":"Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181016_ref1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/joim.12482","article-title":"Clinical and biomarker profiling of prodromal Alzheimer\u2019s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: A \u201cEuropean ADNI study.\u201d","volume":"279","author":"Galluzzi","year":"2016","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-181016_ref2","doi-asserted-by":"crossref","first-page":"P1319","DOI":"10.1016\/j.jalz.2017.06.2024","article-title":"CSF biomarkers and effect of apolipoprotein E genotype, age and sex on cut-off derivation in mild cognitive impairment","volume":"13","author":"Marizzoni","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181016_ref3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-180152","article-title":"Predicting and tracking short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer\u2019s disease: Structural brain biomarkers","volume":"69","author":"Marizzoni","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181016_ref4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-180321","article-title":"Plasma A\u03b242 as a biomarker of prodromal Alzheimer\u2019s disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog\/E-ADNI Study","volume":"69","author":"Albani","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181016_ref5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-180158","article-title":"Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer\u2019s disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity","volume":"69","author":"Jovicich","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-181016_ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-0500-7-25","article-title":"Biomarker selection for medical diagnosis using the partial area under the ROC curve","volume":"7","author":"Hsu","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.3233\/JAD-181016_ref7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1177\/0962280213481053","article-title":"Linear combination methods to improve diagnostic\/prognostic accuracy on future observations","volume":"25","author":"Kang","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"10.3233\/JAD-181016_ref8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/biostatistics\/1.2.123","article-title":"Combining diagnostic test results to increase accuracy","volume":"1","author":"Pepe","year":"2000","journal-title":"Biostatistics"},{"key":"10.3233\/JAD-181016_ref9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-181016_ref10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","article-title":"Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2","volume":"13","author":"Mormino","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181016_ref11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.trci.2017.10.004","article-title":"Optimizing the preclinical Alzheimer\u2019s cognitive composite with semantic processing: The PACC5","volume":"3","author":"Papp","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-181016_ref12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/jnnp-2015-312383","article-title":"ADCOMS: A composite clinical outcome for prodromal Alzheimer\u2019s disease trials","volume":"87","author":"Wang","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-181016_ref13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.trci.2017.01.004","article-title":"A composite measure of cognitive and functional progression in Alzheimer\u2019s disease: Design of the Capturing Changes in Cognition study","volume":"3","author":"Jutten","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-181016_ref14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jalz.2016.06.002","article-title":"Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer\u2019s prevention trial","volume":"12","author":"Coley","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181016_ref15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.192","article-title":"Biomarkers and cognitive endpoints to optimize trials in Alzheimer\u2019s disease","volume":"2","author":"Insel","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-181016_ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.01.013","article-title":"Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)","volume":"53","author":"Nathan","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181016_ref17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State: A practice method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-181016_ref18","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-181016_ref19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1037\/1040-3590.7.4.445","article-title":"Wechsler Memory Scale - Revised","volume":"7","author":"Woodard","year":"1987","journal-title":"Psychol Assess"},{"key":"10.3233\/JAD-181016_ref20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/gps.1375","article-title":"Development of initial validation of a 15-item informant version of the Geriatric Depression Scale","volume":"20","author":"Brown","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-181016_ref21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educ Res Rev"},{"key":"10.3233\/JAD-181016_ref22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.3233\/JAD-181016_ref23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181016_ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","article-title":"A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI","volume":"115","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181016_ref25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.3233\/JAD-181016_ref26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2307\/2533554","article-title":"Sample size calculations for studies with correlated observations","volume":"53","author":"Liu","year":"1997","journal-title":"Biometrics"},{"key":"10.3233\/JAD-181016_ref27","doi-asserted-by":"crossref","first-page":"e0136961","DOI":"10.1371\/journal.pone.0136961","article-title":"Evaluation of multiband EPI acquisitions for resting state fMRI","volume":"10","author":"Preibisch","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-181016_ref28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.tics.2017.09.006","article-title":"Segregated systems of human brain networks","volume":"21","author":"Wig","year":"2017","journal-title":"Trends Cogn Sci"},{"key":"10.3233\/JAD-181016_ref29","first-page":"370","article-title":"Cortical cores in network dynamics","volume":"180(Pt B)","author":"de Pasquale","year":"2017","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181016_ref30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nicl.2013.07.006","article-title":"Effectiveness of regional DTI measures in distinguishing Alzheimer\u2019s disease, MCI, and normal aging","volume":"3","author":"Nir","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-181016_ref31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2011-0023","article-title":"Ultra-high field 7T MRI: A new tool for studying Alzheimer\u2019s disease","volume":"26","author":"Kerchner","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181016_ref32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-181016_ref33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bios.2016.01.065","article-title":"Nano-biosensors to detect beta-amyloid for Alzheimer\u2019s disease management","volume":"80","author":"Kaushik","year":"2016","journal-title":"Biosens Bioelectron"},{"key":"10.3233\/JAD-181016_ref34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Update on hypothetical model of Alzheimer\u2019s disease biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-181016_ref35","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database","volume":"131","author":"Nestor","year":"2008","journal-title":"Brain"},{"key":"10.3233\/JAD-181016_ref36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuroimage.2012.12.052","article-title":"Maximizing power to track Alzheimer\u2019s disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features","volume":"70","author":"Gutman","year":"2013","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181016_ref37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1212\/WNL.0b013e318281ccd3","article-title":"Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration","volume":"80","author":"Leung","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-181016_ref38","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1212\/01.wnl.0000281688.77598.35","article-title":"Atrophy rates accelerate in amnestic mild cognitive impairment","volume":"70","author":"Jack","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-181016_ref39","doi-asserted-by":"crossref","first-page":"e71354","DOI":"10.1371\/journal.pone.0071354","article-title":"Evaluating Alzheimer\u2019s disease progression using rate of regional hippocampal atrophy","volume":"8","author":"Frank\u00f3","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-181016_ref40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2012-111931","article-title":"In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI","volume":"31","author":"Pluta","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181016_ref41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.trci.2016.05.002","article-title":"Proof of concept demonstration of optimal composite MRI endpoints for clinical trials","volume":"2","author":"Edland","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-181016_ref42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.0000000000000824","article-title":"Asymmetry of cortical decline in subtypes of primary progressive aphasia","volume":"83","author":"Rogalski","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-181016_ref43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1474-4422(08)70087-5","article-title":"Endpoints for trials in Alzheimer\u2019s disease: A European task force consensus","volume":"7","author":"Vellas","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-181016_ref44","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1523\/JNEUROSCI.4409-12.2013","article-title":"Alzheimer\u2019s disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals","volume":"33","author":"Wirth","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-181016_ref45","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:31Z","timestamp":1777370971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-181016"}},"subtitle":[],"editor":[{"given":"George","family":"Perry","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-181016","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]}}}